IT1113720B - Procedimento di solubilizzazione di medicinali insolubili - Google Patents

Procedimento di solubilizzazione di medicinali insolubili

Info

Publication number
IT1113720B
IT1113720B IT47942/79A IT4794279A IT1113720B IT 1113720 B IT1113720 B IT 1113720B IT 47942/79 A IT47942/79 A IT 47942/79A IT 4794279 A IT4794279 A IT 4794279A IT 1113720 B IT1113720 B IT 1113720B
Authority
IT
Italy
Prior art keywords
medicinal products
solubilization procedure
insoluble medicinal
insoluble
solubilization
Prior art date
Application number
IT47942/79A
Other languages
English (en)
Other versions
IT7947942A0 (it
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IT7947942A0 publication Critical patent/IT7947942A0/it
Application granted granted Critical
Publication of IT1113720B publication Critical patent/IT1113720B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/609Amides, e.g. salicylamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT47942/79A 1978-02-13 1979-02-08 Procedimento di solubilizzazione di medicinali insolubili IT1113720B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/876,968 US4128632A (en) 1978-02-13 1978-02-13 Solubilization of Rafoxanide

Publications (2)

Publication Number Publication Date
IT7947942A0 IT7947942A0 (it) 1979-02-08
IT1113720B true IT1113720B (it) 1986-01-20

Family

ID=25368975

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47942/79A IT1113720B (it) 1978-02-13 1979-02-08 Procedimento di solubilizzazione di medicinali insolubili

Country Status (18)

Country Link
US (1) US4128632A (it)
EP (1) EP0003682B1 (it)
JP (1) JPS54117019A (it)
AR (1) AR221862A1 (it)
AT (1) AT363600B (it)
AU (1) AU522422B2 (it)
DE (1) DE2962602D1 (it)
DK (1) DK57479A (it)
HU (1) HU177873B (it)
IE (1) IE47833B1 (it)
IT (1) IT1113720B (it)
NZ (1) NZ189536A (it)
OA (1) OA06239A (it)
PH (1) PH13191A (it)
PL (1) PL114317B1 (it)
YU (1) YU25679A (it)
ZA (1) ZA79597B (it)
ZW (1) ZW3579A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
YU43349B (en) * 1983-03-16 1989-06-30 Boehringer Ingelheim Ltd Process for making a watersoluble, pharmaceutically acceptible dispersion of chlortalidone in solid state
US4933360A (en) * 1983-03-16 1990-06-12 Boehringer Ingelheim Pharmaceuticals, Inc. Novel chlorthalidone process and product
WO1987006464A1 (en) * 1986-05-02 1987-11-05 Gaf Corporation Water soluble polyvinyl lactam-drug complexes
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
EP1129713A1 (en) * 2000-02-29 2001-09-05 New Pharma Research Sweden AB Veterinary compositions for the treatment of parasitic diseases
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
DE102010051404B4 (de) 2010-11-16 2017-08-31 Marc de Cocq Verwendung von substituierten Salicylaniliden zur Behandlung von Fischen
DE102012009572A1 (de) 2012-05-15 2013-11-21 Marc de Cocq Die Verwendung von Glycerol-Formal als Lösungsvermittler für pharmazeutische Wirkstoffe bei der Bekämpfung von Fischkrankheiten
CN106176586A (zh) * 2016-07-22 2016-12-07 柳州市柳南区安顺养殖协会 一种牛羊用抗寄生虫病碘醚柳胺透皮溶液

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL184257C (nl) * 1974-06-19 1989-06-01 Merck & Co Inc Werkwijze voor het bereiden van rafoxanide preparaten.

Also Published As

Publication number Publication date
NZ189536A (en) 1981-02-11
AT363600B (de) 1981-08-10
DK57479A (da) 1979-08-14
ATA106679A (de) 1981-01-15
PL114317B1 (en) 1981-01-31
PH13191A (en) 1980-01-16
OA06239A (fr) 1981-06-30
EP0003682B1 (en) 1982-04-28
ZW3579A1 (en) 1980-09-10
DE2962602D1 (en) 1982-06-09
YU25679A (en) 1984-02-29
HU177873B (en) 1982-01-28
AU4391479A (en) 1979-08-23
ZA79597B (en) 1980-10-29
US4128632A (en) 1978-12-05
AU522422B2 (en) 1982-06-03
JPS54117019A (en) 1979-09-11
IE790259L (en) 1979-08-13
EP0003682A1 (en) 1979-08-22
AR221862A1 (es) 1981-03-31
PL213352A1 (it) 1979-12-03
IT7947942A0 (it) 1979-02-08
IE47833B1 (en) 1984-06-27

Similar Documents

Publication Publication Date Title
DK220979A (da) Medicinemballage
ZA793542B (en) Pharmaceutical preparations
IT1133028B (it) Scatola per medicinali
NL7805964A (nl) Medicinaal produkt.
NO149531C (no) Administreringssett
FI792009A (fi) 3-aminopropoxiarylderivat deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar
BE871584A (fr) Preparations pharmaceutiques
JPS55147223A (en) Pharmaceutical medicine
DK348079A (da) Administrationsform
ZA796549B (en) New pharmaceutical preparations
ZA787000B (en) Pharmaceutical formulation
FI791456A (fi) Farmaceutiska foereningar
IT1126406B (it) 1,2,4,5-tetra-alchil-4-arilpiperidine e relative formulazioni farmaceutiche
IT1113720B (it) Procedimento di solubilizzazione di medicinali insolubili
IT7953237V0 (it) Confezione per composizioni radio farmaceutiche
FI792319A (fi) Guargum innehaollande farmaceutisk komposition
IT1115237B (it) Prodotto antireumatico
LU81342A1 (fr) Preparations anti-caries
ZA79395B (en) Pharmaceutical formulations
BE854171A (fr) 2-imino-thiazolidines et thiazolines utiles comme medicaments
IT7950714A0 (it) Ariltrifluoroetanoli procedimento per prepararli e composizioni farmaceutiche che li contengono
FI791701A (fi) Peristaltisk doserare och medelst denna foerverkligat doseringssystem
FI782220A (fi) Oxadiazol-1,2,4-derivat deras framstaellning och deras anvaendning i medicinvaord
IT1117227B (it) Medicinale a base di derivati di tienopiridone e furopiridone e procedimento per preparare detti derivati
PT67995B (fr) Sommier orthopedique

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940117